185 results match your criteria: "Ahmanson-UCLA Adult Congenital Heart Disease Center[Affiliation]"
Heart Rhythm
December 2023
UCLA Cardiac Arrhythmia Center, UCLA Health System, Los Angeles, California.
Background: Patients with repaired tetralogy of Fallot (TOF) are at risk for ventricular tachycardia (VT) related to well-described anatomical isthmuses.
Objective: The purpose of this study was to explore QRS morphology as an indicator of anatomical isthmus conduction.
Methods: Patients with repaired TOF and complete right bundle branch block referred for transcatheter pulmonary valve replacement (PVR) or presenting with sustained VT underwent comprehensive 3-dimensional mapping in sinus rhythm.
Am J Cardiol
October 2023
Montreal Heart Institute, Université de Montréal, Montreal, Que, Canada.
Patients with repaired tetralogy of Fallot are at elevated risk for ventricular arrhythmia and sudden cardiac death. Over the past decade, the pathogenesis and natural history of ventricular tachycardia has become increasingly understood, and catheter ablation has emerged as an effective treatment modality. Concurrently, there has been great progress in the development of a versatile array of transcatheter valves that can be placed in the native right ventricular outflow tract for the treatment of long-standing pulmonary regurgitation.
View Article and Find Full Text PDFInt J Cardiol
October 2023
Division of Cardiology, Ahmanson/UCLA Adult Congenital Heart Disease Center, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States of America.
Introduction: Fontan patients have variable exercise capacity. Contemporary understanding as to which factors predict high tolerance is limited.
Methods: Records from the Ahmanson/University of California, Los Angeles Adult Congenital Heart Disease Center were reviewed for adult Fontan patients who underwent CPET.
Background: The molecular mechanisms underlying Fontan associated liver disease (FALD) remain largely unknown. We aimed to assess intrahepatic transcriptomic differences among patients with FALD according to the degree of liver fibrosis and clinical outcomes.
Methods: This retrospective cohort study included adults with the Fontan circulation at the Ahmanson/UCLA Adult Congenital Heart Disease Center.
JACC Cardiovasc Interv
August 2023
Department of Cardiology, Nationwide Children's Hospital, Columbus, Ohio, USA.
Int J Cardiol
September 2023
Ahmanson/UCLA Adult Congenital Heart Disease Center, Department of Medicine, University of California, Los Angeles, Los Angeles, CA, United States of America; UCLA Cardiac Arrhythmia Center, Department of Medicine, University of California, Los Angeles, Los Angeles, CA, United States of America.
Background: Risk prediction of arrhythmia during pregnancy in adult congenital heart disease (ACHD) patients is currently lacking, and the impact of preconception catheter ablation on future antepartum arrhythmia has not been studied.
Methods: We conducted a single-center, retrospective cohort study of pregnancies in ACHD patients. Clinically significant arrhythmia events during pregnancy were described, predictors of arrhythmia were analyzed, and a risk score devised.
Front Physiol
March 2023
Division of Cardiology, Ahmanson/UCLA Adult Congenital Heart Disease Center, Department of Medicine, University of California Los Angeles Medical Center, Los Angeles, CA, United States.
Conduction system pacing (CSP) has evolved rapidly to become the pacing method of choice for many adults with structurally normal hearts. Studies in this population have repeatedly demonstrated superior hemodynamics and outcomes compared to conventional pacing with the recruitment of the native conduction system. Children and patients with congenital heart disease (CHD) are also likely to benefit from CSP but were excluded from original trials.
View Article and Find Full Text PDFHeart Rhythm
July 2023
Adult Congenital Heart Disease Center and Electrophysiology Service, Montreal Heart Institute, Université de Montréal, Montreal, Quebec, Canada. Electronic address:
JACC Clin Electrophysiol
March 2023
Área de Enfermedades Cardiovasculares, Hospital Universitari i Politècnic La Fe, Centro de Investigaciones Biomédicas en RED en Enfermedades Cardiovasculares, Valencia, Spain.
Background: Dyssynchrony-associated left ventricular systolic dysfunction is a major contributor to heart failure in congenital heart disease (CHD). Although conventional cardiac resynchronization therapy (CRT) has shown benefit, the comparative efficacy of cardiac conduction system pacing (CSP) is unknown.
Objectives: The purpose of this study was compare the clinical outcomes of CSP vs conventional CRT in CHD with biventricular, systemic left ventricular anatomy.
Sci Rep
January 2023
Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Congenital heart disease (CHD) in pregnancy is associated with an increased risk of adverse maternal, obstetric, and neonatal outcomes, plausibly through mechanisms involving abnormal placental development and function. This retrospective study aims to elucidate how maternal CHD influences placental health. Demographic and clinical information were collected via electronic medical record review, and placentas underwent histopathological evaluation.
View Article and Find Full Text PDFJ Am Coll Cardiol
January 2023
Ahmanson/UCLA Adult Congenital Heart Disease Center, Ronald Reagan UCLA Medical Center, Los Angeles, California, USA.
Eur Cardiol
February 2022
Division of Cardiology, Department of Internal Medicine, Northside Cardiovascular Institute, Northside Hospital Atlanta, GA, US.
In the past few decades, the accelerated improvement in technology has allowed the development of new and effective coronary and structural heart disease interventions. There has been inequitable patient access to these advanced therapies and significant disparities have affected patients from low socioeconomic positions. In the US, these disparities mostly affect women, black and hispanic communities who are overrepresented in low socioeconomic.
View Article and Find Full Text PDFEur Heart J Case Rep
December 2022
Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, David Geffen School of Medicine at UCLA, 200 UCLA Medical Plaza, Suites 430 & 220, Los Angeles, CA 90095, USA.
Background: Patients with post-acute sequelae of COVID-19 (PASC) often experience the addition of new symptoms after recovery from COVID-19 illness. These may include orthostatic intolerance and autonomic dysfunction, and postural orthostatic tachycardia syndrome has been described to occur in a proportion of patients with PASC.
Case Summary: In this report, we present a 32-year-old pregnant woman (G3P2) who experiences severe orthostatic symptoms as part of her PASC syndrome, which is decoupled from normal physiologic changes of pregnancy.
J Am Coll Cardiol
December 2022
Division of Cardiology, Inova Children's Hospital, Fairfax, Virginia, USA.
Together, heart failure and arrhythmia represent the most important cardiovascular sources of morbidity and mortality among adults with congenital heart disease (ACHDs). Although traditionally conceptualized as operating within 2 distinct clinical silos, these scenarios frequently coexist within the same individual; consequently the mechanistic, therapeutic, and prognostic overlap between them demands increased recognition. In fact, given the near ubiquity of heart failure and arrhythmia among ACHDs, there is perhaps no other arena within cardiology where this critical intersection is more frequently observed.
View Article and Find Full Text PDFCardiooncology
November 2022
UCLA Cardio-Oncology Program, Division of Cardiology, Department of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.
Background: Malignancy is known to be a major cause of death in adult congenital heart disease (ACHD). However, data regarding cardiovascular and cancer-related outcomes in ACHD are lacking.
Methods: We conducted a retrospective single-center cohort study comprising patients with ACHD and malignancy.
J Am Heart Assoc
November 2022
Department of Cardiology Erasmus MC, University Medical Center Rotterdam The Netherlands.
Background The objective of this international multicenter study was to investigate both early and late outcomes of cardiac resynchronization therapy (CRT) in patients with a systemic right ventricle (SRV) and to identify predictors for congestive heart failure readmissions and mortality. Methods and Results This retrospective international multicenter study included 13 centers. The study population comprised 80 adult patients with SRV (48.
View Article and Find Full Text PDFCirc Arrhythm Electrophysiol
September 2022
Section of Electrophysiology, Cardiology Division, Stanford University, CA (U.N., M.N.V., D.T.N.).
Background: Data on atrial fibrillation (AF) ablation and outcomes are limited in patients with congenital heart disease (CHD). We aimed to investigate the characteristics of patients with CHD presenting for AF ablation and their outcomes.
Methods: A multicenter, retrospective analysis was performed of patients with CHD undergoing AF ablation between 2004 and 2020 at 13 participating centers.
J Am Coll Cardiol
August 2022
Division of Pediatric Cardiology, Department of Pediatrics, Stanford University, Stanford, California, USA.
Background: Palliation of the single ventricle (SV) circulation is associated with a burden of lifelong complications. Previous studies have identified that the need for a permanent ventricular pacing system (PPM) may be associated with additional adverse long-term outcomes.
Objectives: The goal of this study was to quantify the attributable risk of PPM in patients with SV, and to identify modifiable risk factors.
J Soc Cardiovasc Angiogr Interv
August 2022
Ahmanson/UCLA Adult Congenital Heart Disease Center, David Geffen School of Medicine, University of California, Los Angeles, California.
Patients with congenital heart disease now live well into adulthood because of advances in surgical techniques, improvements in medical management, and the development of novel therapeutic agents. As patients grow older into adults with congenital heart disease, many require catheter-based interventions for the treatment of residual defects, sequelae of their initial repair or palliation, or acquired heart disease. The past 3 decades have witnessed an exponential growth in both the type and number of transcatheter interventions in patients with congenital heart disease.
View Article and Find Full Text PDFInt J Cardiol Congenit Heart Dis
December 2022
Ahmanson/UCLA Adult Congenital Heart Disease Center, Los Angeles, California, USA.
Critical congenital heart disease (CCHD) represents a challenging problem in global health equity due to the need for specialized surgical or transcatheter intervention within the first year of life. CCHD screening using pulse oximetry (POS) has led to significant improvements in mortality due to early referral and intervention. Andean America represents one of the few regions in the world with increasing CHD deaths and variable POS implementation.
View Article and Find Full Text PDFJ Am Heart Assoc
August 2022
Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology University of California Los Angeles CA.
Background Current recommendations for delivery timing of pregnant persons with congenital heart disease (CHD) are based on expert opinion. Justification for early-term birth is based on the theoretical concern of increased cardiovascular stress. The objective was to evaluate whether early-term birth with maternal CHD is associated with lower adverse maternal or neonatal outcomes.
View Article and Find Full Text PDFTransplant Proc
September 2022
Ahmanson/UCLA Adult Congenital Heart Disease Center, Los Angeles, California.
J Am Coll Cardiol
August 2022
Boston Adult Congenital Heart Disease Program, Boston Children's Hospital, Boston, Massachusetts, USA; Houston Methodist DeBakey Heart and Vascular Center, Adult Congenital Heart Disease Program, Houston, Texas, USA.
Eur Heart J Case Rep
July 2022
Division of Cardiology, Department of Medicine, Ahmanson-UCLA Adult Congenital Heart Disease Center, David Geffen School of Medicine, University of California, Los Angeles, 200 Medical Plaza, Suite 202, Los Angeles, CA 90095, USA.
Background: Anomalous coronary origin from the left ventricular outflow tract (LVOT) is an exceedingly rare condition thought to be associated with the bicuspid aortic valve (BAV). While the malignant presentation of this entity has been described, its pathophysiology and diagnostic evaluation are poorly understood.
Case Summary: A 33-year-old woman status post Ross procedure in childhood for congenital aortic stenosis due to BAV with presumed common origin of right and left coronary arteries based on single coronary ostium seen on aortic valve inspection, presented with symptomatic pulmonary regurgitation and stenosis.
Catheter Cardiovasc Interv
September 2022
Ahmanson/UCLA Adult Congenital Heart Disease Center, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Transcatheter correction of a superior sinus venosus defect and partial anomalous pulmonary venous connection with covered stents is a feasible alternative to surgical repair in select patients. Commercially available balloon-expandable covered stents may be of inadequate length to treat some patients. This may require multiple stents to be placed, which increases the risk of stent migration or embolization.
View Article and Find Full Text PDF